The Patent Finder

Fronthera U.S. Pharmaceuticals LLC

Also on record
Records under this name other than patents Fronthera U.S. Pharmaceuticals LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 6 of 6 · Back to Fronthera U.S. Pharmaceuticals LLC

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 11,053,219Substituted Pyridines as TYK2 Inhibitors
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 11,964,964Thyroid Hormone Receptor Agonists and Uses Thereof
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,040,972Autotaxin inhibitors and uses thereof
Formerly held
Lapsed on the fee record
Ended Jun 22, 2025 · USPTO record
Lapsed on the fee recordEnded Jun 22, 2025USPTO record
US 11,034,671Apoptosis signal-regulating kinase inhibitors and uses thereof
Formerly held
Lapsed on the fee record
Ended Jun 15, 2025 · USPTO record
Lapsed on the fee recordEnded Jun 15, 2025USPTO record
US 10,787,430Hemoglobin modifier compounds and uses thereof
Formerly held
Lapsed on the fee record
Ended Sep 29, 2024 · USPTO record
Lapsed on the fee recordEnded Sep 29, 2024USPTO record
US 10,711,000Autotaxin inhibitors and uses thereof
Formerly held
Lapsed on the fee record
Ended Jul 14, 2024 · USPTO record
Lapsed on the fee recordEnded Jul 14, 2024USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited